1. Gieler U, Gieler T, Kupfer JP. Acne and quality of life-impact and management. J Eur Acad Dermatol Venereol. 2015; 29:Suppl 4. 12–14.
2. Picardo M, Eichenfield LF, Tan J. Acne and rosacea. Dermatol Ther (Heidelb). 2017; 7:Suppl 1. 43–52.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Lukaviciute L, Navickas P, Navickas A, Grigaitiene J, Ganceviciene R, Zouboulis CC. Quality of life, anxiety prevalence, depression symptomatology and suicidal ideation among acne patients in Lithuania. J Eur Acad Dermatol Venereol. 2017; 31:1900–1906.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Salman A, Kurt E, Topcuoglu V, Demircay Z. Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional controlled study. Am J Clin Dermatol. 2016; 17:305–311.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Yazici K, Baz K, Yazici AE, Köktürk A, Tot S, Demirseren D, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004; 18:435–439.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Mantar A, Yemez B, Alkın T. [The validity and reliability of the Turkish version of the anxiety sensitivity index-3]. Turk Psikiyatri Derg. 2010; 21:225–234. Turkish.
7. Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986; 24:1–8.
![crossref](/image/icon/bnr_ref_cross.gif)
8. McNally RJ. Is anxiety sensitivity distinguishable from trait anxiety? Reply to Lilienfeld, Jacob, and Turner (1989). J Abnorm Psychol. 1989; 98:193–194.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Naragon-Gainey K. Meta-analysis of the relations of anxiety sensitivity to the depressive and anxiety disorders. Psychol Bull. 2010; 136:128–150.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Schmidt NB, Zvolensky MJ, Maner JK. Anxiety sensitivity: prospective prediction of panic attacks and Axis I pathology. J Psychiatr Res. 2006; 40:691–699.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Asmundson GJG, Wright KD, Hadjistavropoulos HD. Anxiety sensitivity and disabling chronic health conditions: state of the art and future directions. Scand J Behav Ther. 2000; 29:100–117.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Dixon LJ, Lee AA, Viana AG, McCowan NK, Brodell RT, Tull MT. Anxiety sensitivity in dermatological patients. Psychosomatics. 2016; 57:498–504.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Dixon LJ, Witcraft SM, McCowan NK, Brodell RT. Stress and skin disease quality of life: the moderating role of anxiety sensitivity social concerns. Br J Dermatol. 2018; 178:951–957.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997; 36:416–418.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Taylor S, Zvolensky MJ, Cox BJ, Deacon B, Heimberg RG, Ledley DR, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. Psychol Assess. 2007; 19:176–188.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Ulusoy M, Sahin NH, Erkmen H. Turkish version of the beck anxiety inventory: psychometric properties. J Cogn Psychother. 1998; 12:163–172.
17. Tuncayengin Ö, Gürel MS, ve Şimşek Z. [Development of Turkish quality of life index in acne vulgaris and its changing with acne severity]. Turk Klinikleri J Dermatol. 2010; 20:117–125. Turkish.
18. Orion E, Wolf R. Psychological factors in skin diseases: stress and skin: facts and controversies. Clin Dermatol. 2013; 31:707–711.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999; 140:672–676.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Demircay Z, Seckin D, Senol A, Demir F. Patient's perspective: an important issue not to be overlooked in assessing acne severity. Eur J Dermatol. 2008; 18:181–184.
21. Golchai J, Khani SH, Heidarzadeh A, Eshkevari SS, Alizade N, Eftekhari H. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals. Indian J Dermatol. 2010; 55:352–354.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Norr AM, Gibby BA, Schmidt NB. Is computerized psychoeducation sufficient to reduce anxiety sensitivity in an atrisk sample?: a randomized trial. J Affect Disord. 2017; 212:48–55.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Smits JA, Berry AC, Tart CD, Powers MB. The efficacy of cognitive-behavioral interventions for reducing anxiety sensitivity: a meta-analytic review. Behav Res Ther. 2008; 46:1047–1054.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011; 49:413–421.
![crossref](/image/icon/bnr_ref_cross.gif)
25. Watt MC, Stewart SH, Lefaivre MJ, Uman LS. A brief cognitive-behavioral approach to reducing anxiety sensitivity decreases pain-related anxiety. Cogn Behav Ther. 2006; 35:248–256.
![crossref](/image/icon/bnr_ref_cross.gif)
26. Jung J, Hwang EJ. Do patients with acne need cognitive behavioral therapy? An analysis of patient knowledge and behavior. Int J Dermatol. 2012; 51:1319–1324.
![crossref](/image/icon/bnr_ref_cross.gif)